Skip to main content


Table 3 Multivariate survival analysis of biochemical recurrence (BCR)-free survival in 128 patients with PCa

From: Association of microRNA-126 expression with clinicopathological features and the risk of biochemical recurrence in prostate cancer patients undergoing radical prostatectomy

Variables BCR-free survival
Exp (B) 95% CI P
Pathological stage 4.11 1.02–8.08 0.001
Lymph node metastasis 3.13 0.81–4.20 0.03
Angiolymphatic invasion 4.62 1.13–9.09 0.001
miR-126 expression 3.68 0.99–6.83 0.01
  1. Note: ‘NS’ refers to the difference without statistic significance.